Recruiting NCT06780475
Validation of in Vitro Method for Anti-MCPyV Immunotherapy on Patients With Cutaneous Merkel Cell Carcinoma
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Merkel Cell Carcinoma of Skin. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Validation of in Vitro Method for Anti-MCPyV Immunotherapy on Patients With Merkel Cell Carcinoma of Skin
Overview
The aim of the study is to test and validate in vitro a cell therapy approach for MCPyV+ Merkel Cell Carcinoma patients.
Detailed description
The aim of the study is to test and validate in vitro a cell therapy approach for MCPyV+ Merkel Cell Carcinoma patients.
Primary outcome measures
- Anti-MCPyV functionality [Time frame: Day 0 and Day 4]
Eligibility criteria
Inclusion criteria
- Patients >= 18 years old;
- Diagnosed with Merkel cell carcinoma of skin, ongoing for local treatment, systemic treatment, complementary treatment or an active follow-up;
- Informed for the study and no-opposed for participation;
- Affiliated with a social security scheme or in an equivalent situation.
Exclusion criteria
- Patients ongoing another interventional clinical trial;
- Patients under guardianship or trusteeship;
- Pregnancy or breastfeed;
- Patients refusal.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
France · 1 center
- Dermato-oncology Department, Ambroise Paré Hospital, APHP — Boulogne-Billancourt
Identifiers
NCT: NCT06780475 · APHP240470 · 2024-A00643-44